Earnings Snapshot: Inovio Pharmaceuticals' Q1 shows EPS beat; net loss $19.7M improves as R&D costs fall

 
[Inovio Pharmaceuticals Q1 report: EPS beats expectations, net loss narrows]
Earnings Snapshot (Seeking Alpha)

MORE ON INOVIO PHARMACEUTICALS

* Inovio Pharmaceuticals, Inc. (INO) Presents at World Federation of Hemophilia World Congress - Slideshow [https://seekingalpha.com/article/4894198-inovio-pharmaceuticals-inc-ino-presents-at-world-federation-of-hemophilia-world-congress]
* Inovio: 'Hold' As Upcoming PDUFA For INO-3107 Is Major Inflection Point [https://seekingalpha.com/article/4888636-inovio-hold-as-upcoming-pdufa-for-ino-3107-is-major-inflection-point]
* Inovio Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4882247-inovio-pharmaceuticals-inc-2025-q4-results-earnings-call-presentation]
* Inovio Pharmaceuticals GAAP EPS of -$0.28 beats by $0.07 [https://seekingalpha.com/news/4592438-inovio-pharmaceuticals-gaap-eps-of-0_28-beats-by-0_07]
* Inovio Pharmaceuticals Q1 2026 Earnings Preview [https://seekingalpha.com/news/4591422-inovio-pharmaceuticals-q1-2026-earnings-preview]